All relevant data are within the paper and its Supporting Information files except the primate gene sequences we cloned, which have been deposited in Genbank (accession numbers: KR062003-KR062043).

Introduction {#sec001}
============

Pathogens constantly drive the evolution of populations they infect \[[@pgen.1005203.ref001],[@pgen.1005203.ref002]\]. The burden of pathogens on host fitness results in selective pressure on both genes involved in immunity and host factors that are hijacked to promote infection. Therefore, alleles providing some measure of resistance to infection rapidly sweep through host populations. Evidence of past selective pressure can be observed at the molecular level by analyzing amino acid sequences for orthologous genes from a large number of related species \[[@pgen.1005203.ref002],[@pgen.1005203.ref003]\]. Changes in the rate of nonsynonymous amino acid substitutions (*d* ~N~) relative to the rate of synonymous changes (*d* ~S~)---also referred to as ω---can indicate recurrent positive selection common to host-pathogen interfaces \[[@pgen.1005203.ref002]\]. Other mechanisms of adaptation might be common at these interfaces as well. For example, evasion might proceed through alternate splicing events that result in isoforms missing surfaces recognized by pathogen inhibitors, but to date few studies have considered alternate mechanisms of adaptive evolution at host-pathogen interfaces.

A set of host genes, termed [p]{.ul}attern [r]{.ul}ecognition [r]{.ul}eceptors (PRRs), initiate immune responses upon recognition of pathogen macromolecular structures (Reviewed in \[[@pgen.1005203.ref004],[@pgen.1005203.ref005]\]). Because such genes act as a "first line" of defense against pathogens, they have been subject to many genetic conflicts involving pathogen-encoded inhibitors that drive recurrent positive selection \[[@pgen.1005203.ref002],[@pgen.1005203.ref006]\]. PRRs recognize pathogen-associated molecular patterns (PAMPs), which include double-stranded RNA (dsRNA) and double-stranded DNA (dsDNA) produced by pathogens \[[@pgen.1005203.ref004],[@pgen.1005203.ref005]\]. Multiple pathways have been described in mammals to detect microorganism-derived nucleic acids in the cell with most acting in the cytoplasm \[[@pgen.1005203.ref004],[@pgen.1005203.ref005]\]. Two of these pathways involve the 2'-5'-[o]{.ul}ligo[a]{.ul}denylate [s]{.ul}ynthase (OAS) family of proteins \[[@pgen.1005203.ref007]\] and the recently described cyclic GMP-AMP synthase (cGAS) \[[@pgen.1005203.ref008]\] which appears to share a distant evolutionary relationship with OAS based on extensive overlap of protein structures \[[@pgen.1005203.ref009]--[@pgen.1005203.ref011]\]. Because PRRs like OAS and cGAS act as crucial sentinels of infection \[[@pgen.1005203.ref007],[@pgen.1005203.ref012],[@pgen.1005203.ref013]\], we set out to compare mechanisms by which they might adapt to pathogen-encoded inhibitors.

OAS proteins are cytoplasmic dsRNA binding proteins that generate the second messenger 2'-5' oligoadenylate (2-5A~n~) (where n \> = 2 and \<20) upon RNA binding \[[@pgen.1005203.ref007]\]. 2-5A leads to the dimerization and activation of the latent ribonuclease (RNase L), which degrades host and viral mRNAs \[[@pgen.1005203.ref013]\]. The core OAS unit consists of a [n]{.ul}ucleo[t]{.ul}idyltransferase (NTase) within the ClassI-CCase family and OAS1-C terminal domain \[[@pgen.1005203.ref007],[@pgen.1005203.ref014],[@pgen.1005203.ref015]\]. The OAS family has a volatile evolutionary history across animals involving domain coupling and multiple gene duplication events \[[@pgen.1005203.ref016],[@pgen.1005203.ref017]\]. In primates, the OAS family consists of OAS1, OAS2, OAS3, and the catalytically inactive OASL, while rodent genomes contain 12 described OAS genes, eight of which are OAS1 paralogs \[[@pgen.1005203.ref017]\]. OAS1 has one core OAS unit while OAS2 and OAS3 have two and three conserved core OAS units in tandem, respectively \[[@pgen.1005203.ref007]\]. OASL encodes one OAS unit followed by a C-terminal domain consisting of two ubiquitin-like repeats and is enzymatically inactive \[[@pgen.1005203.ref018],[@pgen.1005203.ref019]\]. Inhibition of RNA and DNA virus replication mediated by OAS proteins has been experimentally demonstrated \[[@pgen.1005203.ref013],[@pgen.1005203.ref020],[@pgen.1005203.ref021]\] and a viral-encoded direct inhibitor of OAS1 has been described \[[@pgen.1005203.ref022]\].

cGAS provides complementary surveillance as a cytoplasmic double-stranded DNA binding protein \[[@pgen.1005203.ref012]\] that appears to dimerize upon binding of dsDNA \[[@pgen.1005203.ref022],[@pgen.1005203.ref023],[@pgen.1005203.ref024]\]. DNA binding leads to the generation of the second messenger 2'-3'-cyclic GMP-AMP, also known as G(2'-5')pA(3'-5')p or cGAMP, from ATP and GTP by cGAS \[[@pgen.1005203.ref011],[@pgen.1005203.ref025]--[@pgen.1005203.ref028]\]. cGAMP activates the [ST]{.ul}imulator of [I]{.ul}nterferon [G]{.ul}enes (STING) \[[@pgen.1005203.ref025],[@pgen.1005203.ref029]--[@pgen.1005203.ref031]\], which in turn activates transcription of Type I Interferon genes through TBK1-IRF3 signals \[[@pgen.1005203.ref008],[@pgen.1005203.ref029]\]. cGAS has been implicated in the control of DNA viruses \[[@pgen.1005203.ref012],[@pgen.1005203.ref032],[@pgen.1005203.ref033]\] and retroviruses \[[@pgen.1005203.ref034],[@pgen.1005203.ref035]\], which is consistent with a strong preference for dsDNA substrates *in vitro* \[[@pgen.1005203.ref012]\]. cGAS has also been linked to the detection of bacterial DNA \[[@pgen.1005203.ref036],[@pgen.1005203.ref037]\] and even the inhibition of RNA viruses \[[@pgen.1005203.ref032],[@pgen.1005203.ref038]\].

The initial characterization of cGAS highlighted several parallels with OAS mediated defenses ([Fig 1](#pgen.1005203.g001){ref-type="fig"}): 1) nucleic-acid binding, 2) generation of a small nucleotide secondary messenger with a 2'-5'-phosphodiester bond, and 3) viral inhibition. Structural characterization of cGAS revealed that the three-dimensional x-ray crystal structures of OAS1 \[[@pgen.1005203.ref014],[@pgen.1005203.ref015]\] and cGAS share extensive overlap \[[@pgen.1005203.ref009]--[@pgen.1005203.ref011],[@pgen.1005203.ref039]\]. In addition, recent structural characterization of the pathogenic protein DncV from *Vibrio cholerae* \[[@pgen.1005203.ref040]\], which also generates cGAMP, but differs in its phosphodiester linkage (A(3'-5')pG(3'-5')p) and the reaction order \[[@pgen.1005203.ref040],[@pgen.1005203.ref041]\], suggests a deep evolutionary history of the genes involving extensive sequence and functional divergence.

![cGAS and OAS1 act in parallel innate defense signaling pathways.\
**(A)** Model of cGAS signaling. Upon detection and binding of cytoplasmic DNA from viruses (green), cGAS (blue) dimerizes and generates cGAMP, which in turn activates STING signaling (TBK1-IRF3) to promote transcription of interferon beta. **(B)** Model of OAS signaling. Upon detection and binding of double-stranded RNA in the cytoplasm from viruses (green), OAS synthesizes 2--5 oligoadenylate, which activates RNase L and leads to the destruction of viral and cellular RNAs.](pgen.1005203.g001){#pgen.1005203.g001}

Here, we focus on more recent evolution of cGAS and OAS to compare how these nucleic acid sensors have been influenced by selection from pathogens. Consistent with their vital role in immune surveillance \[[@pgen.1005203.ref008],[@pgen.1005203.ref013],[@pgen.1005203.ref039]\], we provide comprehensive evidence that cGAS and OAS1 have been under strong, recurrent positive selection in simian primates. We identified rapidly evolving amino acids sites at homologous positions of a common protein surface on cGAS and OAS1 proteins, supporting the surprising possibility of a shared recent evolutionary history of escape from antagonism by common pathogens. In addition, extensive evolutionary analyses of the primate OAS gene family revealed a novel model of adaptation through repeated gene fusion events. Furthermore, we identified multiple alternate spliced forms of cGAS, which maintain intact ORFs, including ones omitting an exon containing rapidly evolving residues. Together these results yield a wealth of insight into mechanisms of adaptive evolution for key nucleic acid sensors acting as a first line of host defenses against diverse pathogens.

Results {#sec002}
=======

Rapid evolution of cGAS in primates {#sec003}
-----------------------------------

Cyclic GMP-AMP synthase (cGAS), previously referred to as C6ORF150, provides a primary block against viruses \[[@pgen.1005203.ref012],[@pgen.1005203.ref038]\] and intracellular bacteria \[[@pgen.1005203.ref036],[@pgen.1005203.ref037]\]. Following binding of cytoplasmic dsDNA, cGAS generates cGAMP \[[@pgen.1005203.ref012]\]([Fig 1A](#pgen.1005203.g001){ref-type="fig"}), a secondary messenger that activates the interferon response via STING-TBK1-IRF3 signaling \[[@pgen.1005203.ref012],[@pgen.1005203.ref025]\]. Although a study investigating the evolutionary origins of cGAS was recently reported \[[@pgen.1005203.ref042]\] and a limited phylogenetic analysis was conducted \[[@pgen.1005203.ref043]\], little is known about the evolution of cGAS in primates, including humans. Given its crucial role as a DNA sensor triggering innate immunity, and related previous work, we hypothesized that cGAS has been subject to recurrent pathogen-driven evolution in primates.

To determine if cGAS evolved under positive selection in primates, we cloned and sequenced cDNA of cGAS from 22 simian primates (which includes several available primate cGAS sequences from public databases; see [Methods](#sec013){ref-type="sec"} and [S1 Dataset](#pgen.1005203.s025){ref-type="supplementary-material"}) to obtain a dataset representing approximately 40 million years of divergence ([Fig 2A](#pgen.1005203.g002){ref-type="fig"}). Next, we used a combination of maximum likelihood-based algorithms to assess ratios of non-synonymous to synonymous substitution rates (*d* ~N~/*d* ~S~). The sites model implemented in [P]{.ul}hylogenetic [A]{.ul}nalysis by [M]{.ul}aximum [L]{.ul}ikelihood (PAML) \[[@pgen.1005203.ref044]\] calculates *d* ~N~/*d* ~S~ values per amino acid position and compares models that omit or accommodate elevated *d* ~N~/*d* ~S~ to test for positive selection. Our alignment of primate cGAS orthologs revealed signatures of positive selection (p-value \<0.0001) ([S1 Table](#pgen.1005203.s012){ref-type="supplementary-material"} and [S1 Fig](#pgen.1005203.s001){ref-type="supplementary-material"}). We further analyzed cGAS variants using the [PAR]{.ul}titioning approach for [R]{.ul}obust [I]{.ul}nference of [S]{.ul}election (PARRIS) algorithm from the HyPhy package \[[@pgen.1005203.ref045]\], which also accounts for recombination events in the dataset, as well as BUSTED, a related measure to detect gene wide evidence of positive selection \[[@pgen.1005203.ref046]\]. PARRIS and BUSTED revealed complementary evidence for positive selection on cGAS in the primate lineage (p\<0.017 and p\<0.001 respectively) ([S2 Table](#pgen.1005203.s013){ref-type="supplementary-material"} and [S3 Table](#pgen.1005203.s014){ref-type="supplementary-material"}).

![Widespread signatures of positive selection for cGAS and OAS1 across the primate lineage.\
Phylogenetic analyses of cGAS **(A,B)** and OAS1 **(C,D)** were carried out using sequences from 22 matching primate species. **(A)** A species tree displaying sampled primate sequences for cGAS with dN/dS (ω) values obtained from free-ratio analyses (PAML\[[@pgen.1005203.ref045]\], see [Methods](#sec013){ref-type="sec"}) indicated above each branch. ω values \> 1 or at least 3 nonsynonymous: 0 synonymous amino acid changes are labeled in red with the corresponding branch (red branch). **(B)** cGAS gene structure with annotated domains and catalytic residues (below). Amino acid sites with statistically significant ω values obtained from NSsites (PAML \[[@pgen.1005203.ref044]\]), FUBAR, and MEME (HyPhy \[[@pgen.1005203.ref046]\]) are indicated above the gene. **(C)** ω values for OAS1 across primate evolution. The species tree is labeled as described for the cGAS tree. **(D)** OAS1 gene structure with amino acids displaying statistical significant ω values. Actual amino acid residue refers to human reference sequence. Catalytic amino acid residues for both cGAS and OAS1 are indicated within the gene diagram.](pgen.1005203.g002){#pgen.1005203.g002}

To investigate whether cGAS has been subject to episodic positive selection during primate evolution, we calculated *d* ~N~/*d* ~S~ values at each branch in our primate phylogeny using the free-ratio model in PAML. Consistent with a critical role as a host defense gene antagonized by specific viral inhibitors, cGAS exhibits *d* ~N~/*d* ~S~ ratios exceeding one---a hallmark of positive selection---on various branches in hominoid, Old World, and New World monkey lineages ([Fig 2A](#pgen.1005203.g002){ref-type="fig"}). The branch separating ancestors of orangutans from humans, chimps, bonobos, and gorillas in the hominoid lineage was especially remarkable for its inferred episode of positive selection (*d* ~N~/*d* ~S~ = 8.01, 22 inferred nonsynonymous (N): 1 synonymous (S) amino acid changes). We carried out complementary analysis of episodic selection using the GA-Branch and aBSREL test in HyPhy \[[@pgen.1005203.ref047]\]([S2 Fig](#pgen.1005203.s002){ref-type="supplementary-material"} and [S3 Fig](#pgen.1005203.s003){ref-type="supplementary-material"}), which also supports a history of episodic positive selection on cGAS in primates.

Next we analyzed single amino acid sites in cGAS with evidence of positive selection. Amino acid positions with a *d* ~N~/*d* ~S~ \> 1 in innate immune factors have been experimentally demonstrated in several cases to be sites critical for protein-protein interactions between host and pathogen proteins \[[@pgen.1005203.ref002],[@pgen.1005203.ref006]\]. Multiple amino acid sites in cGAS were inferred to have a *d* ~N~/*d* ~S~ ratio significantly greater than 1 ([Fig 2B](#pgen.1005203.g002){ref-type="fig"}). The sites are distributed throughout the protein, a pattern common to other antiviral proteins \[[@pgen.1005203.ref002]\]. Taking advantage of structural studies of cGAS, we mapped sites of selection to a solution of the crystal structure ([Fig 3A](#pgen.1005203.g003){ref-type="fig"} and [S4 Fig](#pgen.1005203.s004){ref-type="supplementary-material"}). While the nucleic acid binding domains of other nucleic acid sensors appear under purifying selection \[[@pgen.1005203.ref006]\], we identified two sites under positive selection in cGAS that make contact with DNA ([S4 Fig](#pgen.1005203.s004){ref-type="supplementary-material"}). The remaining sites under positive selection are located at surface exposed residues on four distinct regions of the protein ([Fig 3A](#pgen.1005203.g003){ref-type="fig"}), consistent with previous observations of other nucleic acid sensors that adapt to evade pathogen-encoded inhibitors \[[@pgen.1005203.ref002],[@pgen.1005203.ref006]\].

![Structurally related cGAS and OAS1 proteins share positions under positive selection.\
Sites under positive selection (red)([Fig 2B](#pgen.1005203.g002){ref-type="fig"} and [Fig 2C](#pgen.1005203.g002){ref-type="fig"}), were mapped onto the apo crystal structure of human cGAS (blue) **(A)** (PDB: 4KM5)\[[@pgen.1005203.ref009]\] and human OAS1 (yellow) **(B)**(PDB: 4IG8)\[[@pgen.1005203.ref014]\]. **(C)** The cGAS and OAS1 crystal structures were merged using Chimera \[[@pgen.1005203.ref069]\] to visualize structural overlap. The merge of the helical spine region of cGAS and OAS1 reveals overlap of at least three sites under positive selection. Black arrows indicate shared sites with the human reference sequence amino acids for cGAS/OAS1. **(D)** An amino acid sequence alignment of cGAS and OAS1 highlights shared sites under positive selection (red) and sequence identity (bold).](pgen.1005203.g003){#pgen.1005203.g003}

Evolutionary analysis of OAS1 suggests shared evolutionary pressures with cGAS {#sec004}
------------------------------------------------------------------------------

Biochemical and other experimental approaches have identified parallels between the OAS and cGAS pathways: 1) binding of viral nucleic acids, 2) generation of small nucleotide secondary messengers containing 2'-5' phosphodiester bonds, and 3) use of these secondary messengers to activate an antiviral response \[[@pgen.1005203.ref012],[@pgen.1005203.ref039]\]. In addition, crystallographic analyses of the cGAS protein \[[@pgen.1005203.ref009]--[@pgen.1005203.ref011],[@pgen.1005203.ref048]\] revealed extensive structural homology between OAS1 and cGAS despite limited overall sequence identity (\~11% amino acid identity). Given these functional relationships, we hypothesized that cGAS and OAS1 might share similar modes of adaptation in response to viral antagonism. To test this idea, we carried out evolutionary analysis of OAS1 using cDNA sequences from the same panel of 22 primate species considered for our analysis of cGAS ([Fig 2C](#pgen.1005203.g002){ref-type="fig"}).

Using PAML and PARRIS or BUSTED in HyPhy, we found that OAS1 is under positive selection in primates (p\<0.001) ([S4](#pgen.1005203.s015){ref-type="supplementary-material"}--[S6](#pgen.1005203.s017){ref-type="supplementary-material"} Tables and [S5 Fig](#pgen.1005203.s005){ref-type="supplementary-material"}), consistent with previous reports with smaller datasets \[[@pgen.1005203.ref049]\]. Branch specific analysis revealed multiple nodes across the primate phylogeny with elevated *d* ~N~/*d* ~S~ values, similar to cGAS ([Fig 2C](#pgen.1005203.g002){ref-type="fig"}). We observed episodic positive selection of OAS1 in each primate lineage, including a notable bout leading to the chimpanzee lineage (12N:0S). Complementary analysis corroborated these findings ([S3 Fig](#pgen.1005203.s003){ref-type="supplementary-material"} and [S6 Fig](#pgen.1005203.s006){ref-type="supplementary-material"}) supporting a history of recurrent adaption of OAS1 in primates.

Similar to cGAS, multiple amino acid positions are under selection in OAS1 ([Fig 2D](#pgen.1005203.g002){ref-type="fig"}). Phylogenetic analysis revealed roughly three times as many sites with statistically significant *d* ~N~/*d* ~S~ ratios compared to our analysis of cGAS. The complementary MEME, and FUBAR tests (HyPhy package) identified multiple residues overlapping with PAML analysis under positive selection in OAS[1](#pgen.1005203.s001){ref-type="supplementary-material"} ([Fig 2D](#pgen.1005203.g002){ref-type="fig"} and [S7 Table](#pgen.1005203.s018){ref-type="supplementary-material"}). These sites are distributed throughout the 364 amino acid protein, a pattern reminiscent of the antiviral Protein kinase R (PKR) \[[@pgen.1005203.ref006]\], and consistent with adaptation of OAS1 to many viral inhibitors.

Structural comparisons reveal a surface with shared sites under positive selection in cGAS and OAS1 {#sec005}
---------------------------------------------------------------------------------------------------

The arrangement of sites under positive selection can predict locations of binding interactions between host and pathogen proteins \[[@pgen.1005203.ref002],[@pgen.1005203.ref006],[@pgen.1005203.ref050]\]. We mapped positively selected sites onto published x-ray crystal structures of human cGAS (Protein Data Bank: 4KM5)\[[@pgen.1005203.ref009]\]([Fig 3A](#pgen.1005203.g003){ref-type="fig"}) and human OAS1 (Protein Data Bank: 4IG8)([Fig 3B](#pgen.1005203.g003){ref-type="fig"})\[[@pgen.1005203.ref014]\] solved in the apo-form, lacking nucleic acid activators and nucleoside triphosphate substrates. Consistent with the idea that rapidly evolving sites are involved in protein-protein interactions, sites with significantly elevated *d* ~N~/*d* ~S~ mapped to protein surfaces of cGAS ([Fig 3A](#pgen.1005203.g003){ref-type="fig"}) and OAS[1](#pgen.1005203.s001){ref-type="supplementary-material"} ([Fig 3B](#pgen.1005203.g003){ref-type="fig"}). For cGAS, the sites under selection localized to four distinct regions of the protein: 1) helix 1 and 2, also referred to as the helical "spine", 2) between helix 11 and 12, 3) between β-sheet 4 and 5, and 4) the unstructured N-terminus which was not crystallized \[[@pgen.1005203.ref009]\]. For OAS1 most protein surfaces, including the helical "spine", contain at least one rapidly evolving site.

Because cGAS and OAS1 share extensive structural homology \[[@pgen.1005203.ref009]--[@pgen.1005203.ref011],[@pgen.1005203.ref048]\], we examined an overlay of the structures to determine if any homologous amino acids or surfaces are rapidly evolving in both proteins. A merge of the two crystal structures highlighting sites under positive selection revealed analogous amino acid positions especially evident on the extended helical spine of the proteins. 4/11 sites in cGAS are located within the spine while 5/36 sites are located along the OAS1 spine as identified by PAML. Close examination of the structures ([Fig 3C](#pgen.1005203.g003){ref-type="fig"}) suggests that three of these sites are analogous based upon the amino acid backbones and the directionality of the side chains: 1) Ser163/Ser11, 2) Asp177/Cys25, and 3) Thr181/Met28 (human amino acid cGAS/amino acid OAS1). Alignment of the cGAS and OAS1 amino acid sequences ([Fig 3D](#pgen.1005203.g003){ref-type="fig"}) corresponding to the helices of the spine indicate that Ser163/Ser11 is an analogous position. Although the sequence alignment implies that Asp177/Cys25 and Thr181/Met28 may not be shared positions, the structure indicates otherwise. Permutation tests simulating co-occurrence of three analogous sites under positive selection in the helical spine suggest that such a pattern of overlap is unlikely to arise by chance (p\<0.001) (see [Methods and Materials](#sec013){ref-type="sec"}, [S1 Dataset](#pgen.1005203.s025){ref-type="supplementary-material"}). Therefore, comparing the location of sites under selection on the merged crystal structures identified distinct and overlapping surfaces under positive selection between cGAS and OAS1.

Similar to cGAS, some sites under positive selection in OAS1 (Protein Data Bank: 4IG8) \[[@pgen.1005203.ref014]\] contact dsRNA ([S7 Fig](#pgen.1005203.s007){ref-type="supplementary-material"}). There are two clusters of sites that contact the sugar phosphate backbone ([S7 Fig](#pgen.1005203.s007){ref-type="supplementary-material"}). The first cluster consisting of Arg47 and Cys54 resides at the C-terminus of the spine is in an unstructured loop between helix αN3 and β1 sheet. The second cluster of sites consists of Thr203, Thr247, and His248 with the latter two in an unstructured loop between helix αC5 and αC5. Collectively, these sites are the first noted as being under positive selection at nucleic-acid binding surfaces for both cGAS and OAS1.

The overlap of positions under positive selection in cGAS and OAS1 prompted us to ask if these host defense genes might have a history of shared antagonism by pathogens during primate divergence. To investigate this idea, we took advantage of our datasets with 22 matching species to determine if there was a correlation between *d* ~N~/*d* ~S~ values on matching branches of the primate lineage. This analysis uncovered evidence of a surprising correlation (R = 0.57; [S8 Fig](#pgen.1005203.s008){ref-type="supplementary-material"}) between *d* ~N~/*d* ~S~ values.

We also tested the correlation of OAS1 and cGAS *d* ~N~/*d* ~S~ values using the maximum likelihood method of Clark and Aquadro \[[@pgen.1005203.ref051]\]. This method employs HyPhy to model a linear correlation between the branch *d* ~N~/*d* ~S~ values of each gene and tests its significance by comparison to a null model with no relationship \[[@pgen.1005203.ref052]\]. A likelihood ratio test between these models supported a correlation between OAS1 and cGAS (P = 0.039) with the slope of in correlation model equal to 0.76. Both this likelihood test and the linear regression of *d* ~N~/*d* ~S~ estimates above support a positive correlation between OAS1 and cGAS. Together these results reveal unexpected parallels in the evolutionary history of OAS and cGAS.

Reduced number of sites under positive selection in OAS2 and OAS3 {#sec006}
-----------------------------------------------------------------

Given extensive positive selection on OAS1, we set out to gain a more complete view of evolution of OAS genes. OAS1 belongs to a multimember gene family consisting of catalytically active OAS1, OAS2, OAS3 and the catalytically inactive OASL in primates \[[@pgen.1005203.ref007]\]. The OAS genes are distinguished by the number of OAS units, which is the number of NTase and OAS1-C domains they contain through gene fusion events involving genomic tandem duplications (OAS1-1 unit, OAS2-2 units, and OAS3-3 units)([Fig 4A](#pgen.1005203.g004){ref-type="fig"})\[[@pgen.1005203.ref007]\]. Among the OAS family, the enzymatically inactive OASL gene uniquely encodes two ubiquitin repeats at its C-terminus \[[@pgen.1005203.ref018],[@pgen.1005203.ref019]\]([Fig 4A](#pgen.1005203.g004){ref-type="fig"}). All four members \[[@pgen.1005203.ref007]\] have been implicated in virus inhibition with OAS1, OAS2, and OAS3 directly activating the 2-5A-RNaseL pathway \[[@pgen.1005203.ref013]\] and OASL acting as an enhancer of RIG-I signaling in infected cells \[[@pgen.1005203.ref053],[@pgen.1005203.ref054]\]. Because OAS1 has strong signatures of positive selection on protein surfaces, we were curious whether the other OAS family members also display signatures of positive selection, given the set of genomic fusion events that resulted in proteins that likely bury interacting surfaces.

![Evolutionary histories vary across the OAS gene family in primates.\
Phylogenetic analyses of OAS1, OAS2, OAS3, and OASL were carried out using sequences from 11 matching primate species. **(A)** Gene structures of the OAS gene family members in primates. NTase (red) and OAS1-C (gray) domains are indicated. For OASL the ubiquitin-like domains (yellow) are also indicated. Amino acid sites with statistically significant ω values obtained from NSsites (PAML \[[@pgen.1005203.ref044]\]), FUBAR, and MEME (HyPhy \[[@pgen.1005203.ref045]\]) are indicated above the gene. **(B)** Primate species trees with ω values obtained from free-ratio analyses in PAML \[[@pgen.1005203.ref044]\] for each lineage. dN/dS values and lineages with ω \> 1 or at least 3 nonsynonymous:0 synonymous amino acid substitutions are highlighted in red.](pgen.1005203.g004){#pgen.1005203.g004}

To determine the evolutionary history of the OAS family in primates, we carried out phylogenetic analysis on a matching panel of primates for all four genes from 11 primates with sequenced genomes and annotated OAS genes ([Fig 4B](#pgen.1005203.g004){ref-type="fig"}, [S9 Fig](#pgen.1005203.s009){ref-type="supplementary-material"}, and [S8](#pgen.1005203.s019){ref-type="supplementary-material"}--[S9](#pgen.1005203.s020){ref-type="supplementary-material"} Tables). Consistent with our observations of the more extensive dataset, OAS1 displayed strong evidence of positive selection across these 11 primates (p\<0.001). OAS2 also displayed signatures of selection (p\<0.014) from analysis by PAML but not from complementary analysis with PARRIS (p = 0.191). A more thorough analysis of OAS2 consisting of 20 species further supports evidence for positive selection by all tests ([S10 Table](#pgen.1005203.s021){ref-type="supplementary-material"} and [S11 Table](#pgen.1005203.s022){ref-type="supplementary-material"}). Moreover, the free-ratio model in PAML identified multiple lineages displaying *d* ~N~/*d* ~S~ \>1 across the 11 primates for both OAS1 and OAS2 ([Fig 4B](#pgen.1005203.g004){ref-type="fig"}). Notably in the 11 species analysis, 22 OAS1 sites were identified as having statistically significant *d* ~N~/*d* ~S~ values as compared to only two sites for OAS2 using the PAML sites model ([Fig 4A](#pgen.1005203.g004){ref-type="fig"}).

In contrast, a comparison of OASL sequences from primates did not exhibit significant signatures of positive selection (p = 0.99), while OAS3 was near the significance cut-off (p = 0.08; [S8 Table](#pgen.1005203.s019){ref-type="supplementary-material"} and [S9 Table](#pgen.1005203.s020){ref-type="supplementary-material"}). A more comprehensive panel of OASL sequences, on par with our analysis of OAS1 and OAS2, also failed to uncover signs of positive selection by all measures tested, including BUSTED ([S12 Table](#pgen.1005203.s023){ref-type="supplementary-material"}). Obtaining a larger panel of OAS3 orthologs was hindered by the large and repetitive nature of the three OAS units encoded by the gene. However, the BUSTED algorithm detected evidence of positive selection in OAS3 (p = 0.024, [S13 Table](#pgen.1005203.s024){ref-type="supplementary-material"}). Analysis of sites under positive selection by PAML, MEME, and FUBAR in matching sets of 11 species for OAS1, OAS2, and OAS3 revealed reduced numbers of sites under selection in inverse correlation with the size of each protein ([Fig 4](#pgen.1005203.g004){ref-type="fig"} and [S7 Table](#pgen.1005203.s018){ref-type="supplementary-material"}). Therefore, in the divergence of the OAS family in primates, OAS1 revealed strong signatures of positive selection compared to OAS2 and OAS3, consistent with the hypothesis that gene fusion events might obscure protein surfaces recognized by pathogen-encoded inhibitors.

Multiple alternately spliced cGAS transcripts {#sec007}
---------------------------------------------

While gene fusions might provide adaptive escape through genetic addition, alternate splicing might provide escape through genetic subtraction. Alternate mRNA spliced variants (spliceforms) are well-documented for contributions to transcript diversity and regulation \[[@pgen.1005203.ref055]\]. Alternative splicing is documented for antiviral proteins, including OAS genes \[[@pgen.1005203.ref007]\]. However, OAS spliceforms have altered C-termini but maintain internal exon structures. By contrast, while cloning cGAS cDNAs, we identified multiple mRNA spliceforms lacking internal exons, some of which encoded intact ORFs. To assess the diversity of cGAS spliceforms across primates, we performed RT-PCR on cDNA extracted from interferon α-treated primary fibroblast cells ([Fig 5A](#pgen.1005203.g005){ref-type="fig"} and [S10 Fig](#pgen.1005203.s010){ref-type="supplementary-material"}).

![cGAS encodes multiple mRNA spliceforms.\
**(A)** A schematic of a PCR based assay to detect cGAS spliceforms. A picture of the cGAS cDNA is shown with positions of primers indicated (black arrows). Amino acid positions at each exon-exon junction are labeled below the cGAS gene structure. **(B)** RT-PCR was carried out using cDNA from primate cell lines representing the major primate families: 1) Hominoids (HOM), Old World (OWM), and New World monkeys (NWM). Expected amplicons size representing spliceforms is indicated (arrows left side). Water was used as a negative control. M = 1kb plus DNA standard. **(C)** cGAS spliceforms identified by cDNA and PCR assay. The exon structure of spliceforms is displayed with the location of stop codon (red stop sign). The size of the spliced amplicons in basepairs (bp) and predicted size of the ORFs in amino acids (aa) are labeled next to the corresponding gene structure. \#: cDNA was identified by cDNA cloning, but not detected by electrophoresis, \*\*\*: stop codon is located 55 nt upstream of last exon-exon junction.](pgen.1005203.g005){#pgen.1005203.g005}

We recovered several alternatively spliced cDNAs of cGAS in hominoid, Old World, and New World Monkey species ([Fig 5B](#pgen.1005203.g005){ref-type="fig"} and [S10 Fig](#pgen.1005203.s010){ref-type="supplementary-material"}), consistent with a varied evolutionary history of transcript variation for cGAS. Sequencing confirmed a diverse set of cGAS mRNA spliceforms ([Fig 5C](#pgen.1005203.g005){ref-type="fig"}), many of which encode intact open-reading frames. Intriguingly, by comparing spliceform structures to a full-length cGAS gene structure we found cDNAs that lack exon 3, which contains a set of sites under positive selection ([Fig 5C](#pgen.1005203.g005){ref-type="fig"}). Strikingly, all of the deletions we mapped remove entire helices or beta-strands at linker region boundaries, as opposed to within such domains, consistent with functional roles of the alternately spliced forms ([S11 Fig](#pgen.1005203.s011){ref-type="supplementary-material"}). These cGAS spliceform variants may represent a means to evade or inactivate counteract viral antagonism or perhaps even regulate cGAS.

Discussion {#sec008}
==========

The Red Queen hypothesis provides a useful framework for investigating recurrent genetic conflicts like those unfolding at host-pathogen interfaces \[[@pgen.1005203.ref056]\]. To date, studying the genetic details of such conflicts has focused on fixed amino acid substitutions in coding regions of genes locked at host-pathogen interfaces. Here we extended such analysis and identified a surprising congruence in cGAS and OAS evolution and also uncovered two potentially adaptive mechanisms involving duplications resulting in gene fusions and alternate splicing of key innate immunity genes.

Evolution of the OAS family suggests adaptation through gene fusion {#sec009}
-------------------------------------------------------------------

OAS proteins are encoded by an ancient and dynamic gene family characterized by extensive duplications in some mammalian lineages \[[@pgen.1005203.ref007],[@pgen.1005203.ref016],[@pgen.1005203.ref017]\]. It is hypothesized that the expansion of the OAS genes involved genomic duplications of the OAS core unit encoded by the first five exons from OAS1 \[[@pgen.1005203.ref016]\]. Because each of these four proteins in primates (OAS1, 2, 3, and L) detect dsRNA from a variety of viruses it is likely that these genes have been involved in genetic conflicts with several inhibitors from different viruses. Consistent with this hypothesis, we identified signatures of positive selection in OAS1 and OAS2, but fewer sites under positive selection in OAS2.

Intriguingly, only a few sites appear under positive selection in OAS3 with even the more sensitive methods of detection ([Fig 4](#pgen.1005203.g004){ref-type="fig"} and [S7 Table](#pgen.1005203.s018){ref-type="supplementary-material"}), despite the fact that it synthesizes 2-5A upon dsRNA binding and can robustly block virus replication \[[@pgen.1005203.ref007],[@pgen.1005203.ref013],[@pgen.1005203.ref057]\]. A potential explanation for these observations is that, despite antiviral functions, OAS2 and OAS3 have not been subject to as many pivotal genetic conflicts imposed by pathogen-encoded inhibitors, as is likely for OAS1. Alternately, the domain duplications and gene fusion events that define OAS2 and OAS3 could themselves be adaptive steps in genetic conflicts over the divergence of primates. In this scenario, gene fusions of OAS2 and OAS3 bury protein surfaces via head-to-tail duplications and result in proteins resistant to viral inhibitors that target homotypic interactions ([Fig 6](#pgen.1005203.g006){ref-type="fig"}). Consistent with this idea is the fact that OAS2 has roughly half as many sites under positive selection as OAS1, and OAS3 half as many as OAS2 ([Fig 4](#pgen.1005203.g004){ref-type="fig"} and [S7 Table](#pgen.1005203.s018){ref-type="supplementary-material"}). Furthermore, while OAS1 appears active as a monomer, its activity might be enhanced or modulated by homotypic interactions or self-assembly \[[@pgen.1005203.ref058]\]. As a consequence, some viral inhibitors might act to block OAS1 interactions. Future work will help determine whether, in addition to amino acid substitutions at individual sites under positive selection, gene fusions can provide single mutational steps that obscure protein surfaces from interactions with viral encoded inhibitors.

![Proposed models for shared and distinct modes of adaptation for cGAS and OAS proteins in primates.\
An ancestral protein (red) with template independent polymerase activity was challenged by pathogens (green), which led to gene duplications and divergence resulting in ancestral cGAS (blue) and ancestral OAS (yellow). cGAS and OAS likely faced shared and distinct inhibitors encoded by pathogens (colored hexagons). Extensive positive selection of cGAS and OAS resulted in a variety of substitutions that evade inhibition by pathogens. For cGAS, sampling of amino acid substitutions on protein surfaces (gray stars) and the expression of spliceforms that may produce molecular mimics or cGAS variant proteins that evade antagonism could provide diverse mechanisms of escape from pathogen-encoded inhibitors. Some OAS genes also fix amino acid substitutions (gray stars) and may also evade pathogens via duplications and gene fusion events evident in OAS2 and OAS3.](pgen.1005203.g006){#pgen.1005203.g006}

Alternative spliced forms of cGAS may evade viral inhibitors {#sec010}
------------------------------------------------------------

As another potentially adaptive mechanism we identified multiple primate cGAS isoforms that encode intact ORFs. Intriguingly we found four isoforms that cleanly excise all of exon 3 from cGAS, which contains three sites under positive selection. Importantly, spliceforms that lack exon 3 but maintain exon 2 still contain the cGAMP catalytic residues. Based on published cGAS domain deletion data \[[@pgen.1005203.ref012]\] and the presence of catalytic residues, it is possible that all identified cGAS spliceforms retain DNA binding activity owing to the presence of exon 1. In addition, although spliceform 1, 2, and 4 ([Fig 5C](#pgen.1005203.g005){ref-type="fig"} and [S11 Fig](#pgen.1005203.s011){ref-type="supplementary-material"}) might synthesize cGAMP, it is possible that exon loss may disrupt protein folding. Indeed, it will be necessary to experimentally determine whether any cGAS spliceforms provide adaptive antiviral activity in future work. We posit that these isoforms may serve to remove surfaces antagonized by pathogens, consistent with the loss of several sites under positive selection or that the spliceforms may act as cGAS decoys that bind and sequester viral or bacterial inhibitors.

Regardless of mechanism, alternative splicing has been noted in several cases for evasion of pathogens. Alternative splicing of human APOBEC3G, 3F, and 3H has been documented with varying impacts on antiviral activity and susceptibility to Vif antagonism \[[@pgen.1005203.ref059],[@pgen.1005203.ref060]\]. Supporting the idea that removal of a protein surface may aid in evasion of viral antagonism, one APOBEC3F isoform was noted for resistance to Vif-mediated degradation \[[@pgen.1005203.ref059]\]. On the other hand, another isoform is more susceptible to Vif-mediated degradation \[[@pgen.1005203.ref059]\]. In addition, mutations leading to small deletions have been described for genes targeted by viruses. Of particular interest are a five amino acid deletion in the cytoplasmic tail of human tetherin, which lacks a site under positive selection, that disrupts the functional interaction with the lentivirus encoded antagonist Nef \[[@pgen.1005203.ref061]\], as well as alternately translated forms that resist HIV-1 \[[@pgen.1005203.ref062]\]. Alternatively, it is possible that some of the cGAS spliceforms we identified may serve as antimorphic, negative regulators of cGAS signaling, in a manner analogous to the recently described mini-MAVS variants that modulate the activity of the innate defense factor MAVS \[[@pgen.1005203.ref063]\].

cGAS and OAS1 have overlapping evolutionary histories in primates {#sec011}
-----------------------------------------------------------------

Consistent with their critical role as PRRs \[[@pgen.1005203.ref005],[@pgen.1005203.ref064]\], our analysis indicates that both cGAS and OAS1 are rapidly evolving and reveals a potentially overlapping history of escape from antagonism by common viral inhibitors ([Fig 2](#pgen.1005203.g002){ref-type="fig"}). Similar to other PRRs known to recognize nucleic acids as substrates \[[@pgen.1005203.ref002],[@pgen.1005203.ref006]\], both cGAS and OAS1 have sites distributed throughout the gene with signatures of positive selection ([Fig 2B](#pgen.1005203.g002){ref-type="fig"} and [Fig 2D](#pgen.1005203.g002){ref-type="fig"}). A broad distribution of sites under positive selection is consistent with rapid evolution in response to interactions with inhibitors encoded by multiple pathogens as has been observed for several host defense genes, including the antiviral Protein kinase R \[[@pgen.1005203.ref002],[@pgen.1005203.ref006]\]. That these signatures of adaptive evolution might reflect genetic conflicts with multiple inhibitors is consistent with the fact that OAS1 and cGAS detect multiple pathogens \[[@pgen.1005203.ref015],[@pgen.1005203.ref032],[@pgen.1005203.ref033],[@pgen.1005203.ref035],[@pgen.1005203.ref038],[@pgen.1005203.ref065]\]. Furthermore, although cGAS exhibits only about a third the number of sites under selection compared to OAS1, the robust signatures of selection we observed strongly predict the existence of multiple direct inhibitors of cGAS that have yet to be discovered.

The localization of amino acid positions under positive selection can identify new interfaces involved in protein-protein interactions between host and pathogen factors \[[@pgen.1005203.ref002]\]. Notably, although some protein domains may be dispensable for basal activity in the context of innate immunity, these domains may have as of yet undefined roles in regulation or may be targeted by pathogen factors to inactivate PRRs. For instance, the unstructured N-terminal 160 amino acids of cGAS are dispensable for cGAS activity *in vitro* and *in vivo* \[[@pgen.1005203.ref012]\]. However, we identified several sites under positive selection within the cGAS N-terminus. Although the N-terminus is the least conserved domain of cGAS \[[@pgen.1005203.ref012]\], the statistically significant *d* ~N~/*d* ~S~ ratios for these sites (posterior probability \>0.99) suggest that this domain may be a prime target for pathogen inhibitors of cGAS.

In addition to identifying three structurally homologous rapidly evolving sites along the spine of both OAS1 and cGAS ([Fig 3](#pgen.1005203.g003){ref-type="fig"}), we find evidence of an intriguing correlation between rates of evolution (*d* ~N~/*d* ~S~ values) for matching branches in the primate tree ([Fig 2A](#pgen.1005203.g002){ref-type="fig"}, [Fig 2C](#pgen.1005203.g002){ref-type="fig"}, and [S8 Fig](#pgen.1005203.s008){ref-type="supplementary-material"}). This correlation of overall rates of evolution suggests that cGAS and OAS1 may have been subject to inhibition on the same primate branches---and perhaps even by the same pathogen or groups of pathogens---over the course of primate divergence. We hypothesize that double-stranded DNA viruses, such as poxviruses that replicate in the cytoplasm, represent strong candidates for encoding such inhibitors because they produce both double-stranded RNA and DNA and deploy inhibitors of immune functions. Consistent with this hypothesis is the observation that some viruses, such as poxviruses, are sensed by both cGAS \[[@pgen.1005203.ref012],[@pgen.1005203.ref032],[@pgen.1005203.ref066]\] and OAS1 \[[@pgen.1005203.ref021]\]. One known herpesvirus inhibitor of OAS1 is Us11 \[[@pgen.1005203.ref022]\], which in light of these data, is also an intriguing candidate that remains to be tested for inhibition of cGAS.

Conclusions {#sec012}
-----------

The recent discovery of cGAS as the basis of a crucial nucleic acid sensing function has generated considerable interest in characterizing this newly described host defense \[[@pgen.1005203.ref012],[@pgen.1005203.ref025]\]. Not only can cGAS sense and respond to a variety of pathogens, it has also been postulated to provide a means of spreading intercellular signals of infection via its generation of the secondary messenger cGAMP \[[@pgen.1005203.ref067]\]. Our evolutionary analysis of cGAS over the divergence of primates is consistent with a vital function for cGAS in countering diverse pathogens. These data further predict the existence of at least several pathogen-encoded inhibitors of cGAS, which will be important to identify and characterize to gain a better understanding of the role of cGAS in countering infections.

Another insight into cGAS evolution was the recent observation of extensive overlap in structure with the nucleic acid sensor, OAS1 \[[@pgen.1005203.ref009]--[@pgen.1005203.ref011],[@pgen.1005203.ref048]\]. These data suggest a deep evolutionary connection between the genes and also led us to discover a correlation of positive selection among cGAS and OAS1 during primate evolution as well as shared positions under positive selection. These data suggest a shared history of antagonism by inhibitors deployed by pathogens. Finally, both cGAS and OAS genes appear to adapt by additional mechanisms that drastically alter protein structure through alternate splicing or gene fusion events respectively. Taken together this study reveals central roles for cGAS and OAS genes as key sentinels of host defense in the descent of primates.

Methods and Materials {#sec013}
=====================

Sequence analysis {#sec014}
-----------------

DNA Sequences from primates with sequenced genomes were retrieved from the NCBI database using BLAST searches or from the UCSC genome browser (genome.ucsc.edu) using BLAT searches. For other primates, sequences were obtained by Sanger sequencing of PCR amplicons using cDNA as a template or genomic DNA. Briefly, cDNA was synthesized using Superscript III mastermix (Life Technologies) or Maxima cDNA synthesis kit (Thermo) from total RNA extracted from fibroblast cell lines obtained from Coriell. Sequences of interest were PCR amplified from cDNA using Phusion High-Fidelity mastermix (Thermo) according to the manufacturer's instructions and analyzed by 1--2% agarose gel electrophoresis. Amplicons of interest were excised, purified using Zymo gel extraction kit, and subject to Sanger sequencing or TOPO cloned (Life Technologies) followed by sequencing. For cGAS sequences from New World Monkeys, each exon was PCR amplified from genomic DNA. DNA sequences were analyzed using Geneious software.

DNA sequence alignments were carried out using MUSCLE with default settings in Geneious. All sequences are available in [S1 Dataset](#pgen.1005203.s025){ref-type="supplementary-material"}. Genbank accession numbers KR062003-KR062043.

Evolutionary analysis {#sec015}
---------------------

DNA sequences were manually trimmed to remove indels and aligned using Geneious v6.1.7 (Biomatters Ltd.) using default settings. This alignment and a species trees representing currently accepted primate relationships \[[@pgen.1005203.ref068]\] were used as input files for PAML analysis \[[@pgen.1005203.ref044]\] and additional analyses using HyPhy software on Datamonkey.org \[[@pgen.1005203.ref045]\].

We carried out permutation tests by generating two vectors representing cGAS and OAS1 of length 40 to represent 40 amino acids of the helical spine. Executing 1,000,000 trials we determined the probability of getting three sites overlapping between the two vectors (the R script is included in [S1 Dataset](#pgen.1005203.s025){ref-type="supplementary-material"}).

Modeling {#sec016}
--------

Amino acids identified as being under positive selection using PAML and Datamonkey were mapped onto the three-dimensional crystal structures of the apoform of cGAS (PDB: 4KM5)\[[@pgen.1005203.ref009]\] and DNA co-crystal with mouse cGAS (PDB:406A) \[[@pgen.1005203.ref024]\] and human OAS1 (PDB: 4IG8) \[[@pgen.1005203.ref014]\] using Chimera software (<http://www.cgl.ucsf.edu/chimera/>)\[[@pgen.1005203.ref069]\].

RT-PCR {#sec017}
------

Total RNA from primate fibroblast cell lines treated with 1000 U of interferon/mL was extracted using the RNAeasy kit (Qiagen). 1--2 μg of total RNA was reverse-transcribed using the Maxima cDNA synthesis kit (Thermo). cDNA was diluted to a final volume of 50 μL of which 1 μl was used as a template for PCR. PCR was carried using Phusion according to the manufacturer's protocol for 35 cycles using cGAS Fint 5'-accgggagctactatgagca-3' and cGAS Rint 5'-tgtcctgaggcactgaagaa-3'primers. PCR amplicons were analyzed using 2% agarose gel electrophoresis.

Supporting Information {#sec018}
======================

###### cGAS gene tree.

A phylogenetic tree produced by the PhyML plugin in Geneious using 22 primate cGAS cDNA sequences.

(EPS)

###### 

Click here for additional data file.

###### Lineages identified by GA-Branch implemented in HyPhy Datamonkey as rapidly evolving for cGAS.

Lineages identified by GA-Branch as being subject to positive selection are labeled in red.

(EPS)

###### 

Click here for additional data file.

###### Primate phylograms for A) cGAS and B) OAS1 displaying ω values calculated at branches by aBSREL analysis \[[@pgen.1005203.ref047]\].

In instances where aBSREL was unable to calculate a value (S = 0), the number of nonsynonymous changes relative to synonymous changes calculated by PAML free-ratio analysis are shown. Lineages displaying ω \> 1 or at least 3 nonsynonymous changes are highlighted in red.

(EPS)

###### 

Click here for additional data file.

###### cGAS protein evolution occurs at both DNA binding pockets.

\(A\) The co-crystal of the mouse cGAS dimer with dsDNA (PDB:406A) with sites under positive selection (red). (B and C) Two interfaces where cGAS sites under positive selection interact with DNA. Each cGAS monomer is individually colored either blue or turquoise. (D) Amino acid alignment of primate variation for the two cGAS rapidly evolving sites that contact DNA in the mouse dimer crystal structure.
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###### 

Click here for additional data file.

###### OAS1 gene tree.

A phylogenetic tree produced by the PhyML plugin in Geneious using 22 primate cGAS cDNA sequences.

(EPS)

###### 

Click here for additional data file.

###### Lineages identified by GA-Branch implemented in HyPhy Datamonkey as rapidly evolving for OAS1.

Lineages identified by GA-Branch as being subject to positive selection are labeled in red.

(EPS)

###### 

Click here for additional data file.

###### Some sites under positive selection in OAS1 are found at the double-stranded RNA binding interface.

\(A\) The co-crystal of OAS1 (yellow) and dsRNA (silver) with sites under positive selection labeled in red. (B and C) Two OAS1 protein surfaces that interact with dsRNA are highlighted. (D) Amino acid alignment showing primate variation for OAS1 at rapidly evolving sites that contact RNA in the crystal structure.
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Click here for additional data file.

###### Rates of evolution (measured as the *d* ~N~/*d* ~S~ ratio) are correlated between the pattern recognition receptors cGAS and OAS1.

Models of sequence evolution were used to estimate the rate of each protein on each branch of our primate tree. Plotting each branch by its rate in OAS1 and cGAS reveals a clear linear correlation, indicating that rapid evolution in one gene is typically paralleled by rapid evolution in the other gene. Rates were estimated in the free-ratio branch model of PAML. The correlation analysis was restricted to branches with sufficient divergence to provide reliable estimates of *d* ~N~/*d* ~S~, specifically those with *d* ~S~ \> 0.01.
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Click here for additional data file.

###### Primate phylogram for OAS gene family displaying ω values calculated at branches by aBSREL analysis \[[@pgen.1005203.ref047]\]

. In instances where aBSREL was unable to calculate a value (S = 0), the number of nonsynonymous changes relative to synonymous changes calculated by PAML free-ratio analysis are shown. Lineages displaying ω \> 1 or at least 3 nonsynonymous changes are highlighted in red.
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###### 

Click here for additional data file.

###### RT-PCR of primate cGAS spliceforms using oligo dT primed cDNA template.

\(A\) cGAS RT-PCR splicing assay. (B) cGAS spliceform RT-PCR amplicons resolved by 2% agarose gel electrophoresis. Numbering of spliceforms the same as in [Fig 5](#pgen.1005203.g005){ref-type="fig"}. Total RNA was isolated from primate fibroblast cell lines (Coriell) using the RNeasy (QIAGEN) kit. First-strand cDNA was synthesized using 4μg of total RNA and Superscript III (Invitrogen) with oligo dT as a primer. cDNA was diluted up to a final volume of 100 μL of which 1μl was used for PCR. PCR amplification was carried out using Phusion (NEB) for 35 cycles. Primer sequences are listed in methods and are the same as those used in [Fig 5](#pgen.1005203.g005){ref-type="fig"}. α = 24 hour Interferon α treatment, γ = 24 hour Interferon γ treatment, cDNA synthesis was performed using the Maxima cDNA synthesis mastermix (Thermo), using oligo dT for priming, M = 100 bp DNA marker.
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###### 

Click here for additional data file.

###### cGAS spliceform sequences mapped onto the full-length cGAS structure.

cGAS spliceform variant predicted sequences ([Fig 5B](#pgen.1005203.g005){ref-type="fig"}) are highlighted (B-F) on the crystal structure of human cGAS (PDB:4KM5) \[[@pgen.1005203.ref009]\] (A). Spliceform variant (V) numbering is the same as in [Fig 5](#pgen.1005203.g005){ref-type="fig"}. Structures in blue indicate remaining sequences following splicing. Silver indicates sequences removed by splicing. Red indicates amino acids identified by PAML analysis as rapidly evolving (see [Fig 2](#pgen.1005203.g002){ref-type="fig"}). Δ = denotes which exons are removed during mRNA splicing.
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Click here for additional data file.

###### cGAS gene log likelihood scores and parameter estimates for four models of variable ω among sites assuming the f3x4 model of codon frequencies.

(DOCX)

###### 

Click here for additional data file.

###### Likelihood ratio test statistics for PARRIS analysis of cGAS gene.

(DOCX)

###### 

Click here for additional data file.

###### Likelihood ratio test statistics for BUSTED analysis of cGAS gene (22 species).

(DOCX)

###### 

Click here for additional data file.

###### OAS1 gene log likelihood scores and parameter estimates for four models of variable ω among sites assuming the f3x4 model of codon frequencies.

(DOCX)

###### 

Click here for additional data file.

###### Likelihood ratio test staistics for PARRIS analysis of OAS1 gene.

(DOCX)

###### 

Click here for additional data file.

###### Likelihood ratio test statistics for BUSTED analysis of OAS1 gene (22 species).

(DOCX)

###### 

Click here for additional data file.

###### Rapidly evolving sites identified by evolutionary analysis.

(XLSX)

###### 

Click here for additional data file.

###### OAS gene family evolutionary summary for 11 primate species using PAML.

(DOCX)

###### 

Click here for additional data file.

###### OAS gene family log likelihood scores and parameter estimates for two models of variable ω among sites assuming the f3x4 model of codon frequencies in PAML.

(DOCX)

###### 

Click here for additional data file.

###### OAS2 gene (20 species) log likelihood scores and parameter estimates for four models of variable ω among sites assuming the f3x4 model of codon frequencies.

(DOCX)

###### 

Click here for additional data file.

###### Likelihood ratio test statistics for BUSTED analysis of OAS2 gene (20 species).

(DOCX)

###### 

Click here for additional data file.

###### Likelihood ratio test statistics for BUSTED analysis of OASL gene (21 species).

(DOCX)

###### 

Click here for additional data file.

###### Likelihood ratio test statistics for BUSTED analysis of OAS3 gene (11 species).
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Click here for additional data file.

###### 

(TXT)

###### 

Click here for additional data file.
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